You and Eye: Unearthing the true prevalence of keratoconus - with Andrew S. Morgenstern, OD, FAAO, FNAP

News
Podcast

Andrew S. Morgenstern, OD, FAAO, FNAP, joins Dr. Korik to discuss a newly published study on the incidence of keratoconus among pediatric patients in a Chicago-based study. The pair also discuss the International Keratoconus Academy, and Morgenstern's experience working at Walter Reed Medical Center.

Andrew S. Morgenstern, OD, FAAO, FNAP, joins Dr. Korik to discuss a newly published study on the incidence of keratoconus among pediatric patients in a Chicago-based study. The pair also discuss the International Keratoconus Academy, and Dr. Morgenstern's experience working at Walter Reed Medical Center.

*Editor's note: Around 8:47, Dr. Korik says corneal crosslinking was not in the US as of 2013. However, it was being used off-label at that time but had not been FDA approved for keratoconus.

To learn more about IKA or to join the organization, visit their website: https://www.keratoconusacademy.com/

Prefer to listen on the go? You can follow the podcast on Spotify and Apple Podcasts.

Follow Dr Korik on social media:
Instagram: @mirrrcatt, @dr_miri_k
Facebook: https://www.facebook.com/msk1010xoxo
LinkedIn: https://www.linkedin.com/in/miriam-korik-81b492111/
YouTube: https://www.youtube.com/channel/UCuIVJVZ17AJFEo8fqXK_gZg

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
© 2025 MJH Life Sciences

All rights reserved.